Models
| Submission ID |
Name
|
Format | Submitter | Submitted | Modified | Certification |
|---|---|---|---|---|---|---|
| DDMODEL00000229 | A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML) | PharmML | Moran Optimata | 2016/10/26 | 2016/11/01 |
|
Showing 151 to 151 of 151 models

Last


